<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
    
    <url>
        <loc>http://ectd.with-ies.work/contactus</loc>
        <lastmod>2026-07-02</lastmod>
    </url><url>
        <loc>http://ectd.with-ies.work/pharmagate</loc>
        <lastmod>2026-07-04</lastmod>
    </url><url>
        <loc>http://ectd.with-ies.work/terms</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/anamol-paracetamol-sugar-free-suspension-strawberry-flavour-14</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/aminocycline-500gm-20gm-3</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/asenapine-hikma-pharma-5mg-sublingual-tablets-6</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/atcogliflozin-empagliflozin-5</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/b11-amp1-18</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/co-pack-ors-with-zinc-childhood-diarrhea-treatment-developed-with-unicef-17</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/differine-gel-adapalene-dermatology-12</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/effegad-75mg-er-venlafaxine-extended-release-capsules-7</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/lamozid-lamivudinezidovudine-who-prequalified-antiretroviral-16</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/odia-4mg-glimepiride-30-tablets-10</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/ospamox-500mg-amoxicillin-12-dispersible-tablets-8</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/spaq-sulfadoxine-pyrimethamine-amodiaquine-antimalarial-who-prequalified-15</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/tovoniza-4</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/tricef-1g-ceftriaxone-imiv-9</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/xedilol-25mg-carvedilol-30-tablets-11</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop/zyloric-300mg-allopurinol-28-tablets-13</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/shop</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/sell</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/seller/list</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/seller_shop</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/website/info</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/company-spotlights-6</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/country-profile-3</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/knowledge-center-7</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/pharmagate-news-8</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/pharmaceutical-regulatory-agreements-mous-9</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/regulatory-insights-2</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/tenders-procurement-4</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/trade-missions-delegations-5</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/company-spotlights-6/feed</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/country-profile-3/feed</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/knowledge-center-7/feed</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/pharmagate-news-8/feed</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/pharmaceutical-regulatory-agreements-mous-9/feed</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/regulatory-insights-2/feed</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/tenders-procurement-4/feed</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/trade-missions-delegations-5/feed</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10/feed</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/country-profile-3/south-africas-sahpra-traceability-roadmap-to-2031-8</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/country-profile-3/kenya-as-east-africas-distribution-gateway-7</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/country-profile-3/nigerias-nafdac-track-trace-what-importers-need-to-know-now-6</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/country-profile-3/egypt-north-africas-pharmaceutical-manufacturing-hub-5</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/knowledge-center-7/common-reasons-african-regulatory-submissions-get-delayed-20</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/knowledge-center-7/afcfta-and-pharma-tariff-reduction-non-tariff-barriers-whats-real-19</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/knowledge-center-7/the-african-medicines-agency-explained-structure-phases-what-it-means-for-you-18</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/knowledge-center-7/ctd-vs-ectd-whats-the-actual-difference-17</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/pharmaceutical-regulatory-agreements-mous-9/why-25-countries-still-havent-ratified-the-ama-treaty-24</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/pharmaceutical-regulatory-agreements-mous-9/egyptsouth-africa-pharmaceutical-and-automotive-mou-in-progress-23</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/pharmaceutical-regulatory-agreements-mous-9/emas-10m-grant-to-support-amas-launch-22</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/pharmaceutical-regulatory-agreements-mous-9/the-2025-africa-cdcauda-nepad-mou-mutual-reliance-among-who-ml3-authorities-21</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/regulatory-insights-2/pmda-mandates-ectd-v40-is-ema-next-4</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/regulatory-insights-2/as2-gateway-vs-web-client-choosing-your-ema-submission-channel-3</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/regulatory-insights-2/ectd-validation-rules-why-submissions-get-refused-to-file-2</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/regulatory-insights-2/eu-ectd-v40-vs-v322-what-changes-on-15-july-2026-1</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/tenders-procurement-4/importing-into-ghana-nigeria-kenya-permit-systems-compared-12</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/tenders-procurement-4/where-to-find-live-african-health-tenders-11</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/tenders-procurement-4/sahpra-licensing-the-non-negotiable-for-south-african-government-tenders-10</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/tenders-procurement-4/how-to-read-a-healthcare-tender-evaluation-criteria-that-actually-matter-9</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/trade-missions-delegations-5/aim2030-world-bank-initiative-piloting-in-9-african-countries-16</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/trade-missions-delegations-5/edas-delegation-diplomacy-japan-denmark-saudi-arabia-15</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/trade-missions-delegations-5/egyptrwanda-egyptlebanon-bilateral-pharma-deals-signed-at-excon-2026-14</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/trade-missions-delegations-5/africa-health-excon-2026-recap-seven-priorities-for-health-sovereignty-13</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10/personal-import-32</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10/pharmacovigilance-service-31</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10/registration-service-30</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10/ectd-service-29</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10/distributor-identification-why-local-partnerships-make-or-break-market-entry-28</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10/regulatory-strategy-for-first-time-african-market-entrants-27</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10/ectd-compilation-as-a-service-when-to-outsource-vs-build-in-house-26</loc>
    </url><url>
        <loc>http://ectd.with-ies.work/blog/value-added-services-10/gmp-readiness-what-a-gap-analysis-actually-covers-25</loc>
    </url>
</urlset>